ICON PROSTAC
Natural health product licensed in Canada
- Licence holder
- Viva Pharmaceutical Inc.
- NPN or DIN-HM
- 80104650
- Status
- Active licence
- Licence date
- 29 September 2020
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Gélatine, Dioxyde de titane, Lécithine, Rouge FD&C N° 40, Cire d'abeille jaune, Huile de fève de soja, Glycérine, Eau purifiée, Laque d'aluminium bleu FD&C n° 1, Laque d'aluminium jaune FD&C No. 6
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Juniper is traditionally used in Herbal Medicine as a diuretic. Juniper is traditionally used in Herbal Medicine as a urinary tract antiseptic to help relieve benign urinary tract infections. Source of oleic acid. Helps to support prostate health. Provides antioxidants for the maintenance of good health. Helps in connective tissue formation. Helps to maintain healthy skin. Helps to maintain immune function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80104650
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.